Cargando…

Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma

OBJECTIVES: Oral squamous cell carcinoma (OSCC) is a commonly reported cancer in men and is second only to breast cancer in women in Pakistan.. Investigations for identifying biomarkers of OSCC are essential for diagnostic, therapeutic, or prognostic significance. This study aims to examine the miR-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Parma, Syed, Sofia A., Wahid, Mohsin, Qureshi, Muhammad A., Kumar, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taibah University 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498719/
https://www.ncbi.nlm.nih.gov/pubmed/34690655
http://dx.doi.org/10.1016/j.jtumed.2021.03.007
_version_ 1784580228389011456
author Kumari, Parma
Syed, Sofia A.
Wahid, Mohsin
Qureshi, Muhammad A.
Kumar, Rajesh
author_facet Kumari, Parma
Syed, Sofia A.
Wahid, Mohsin
Qureshi, Muhammad A.
Kumar, Rajesh
author_sort Kumari, Parma
collection PubMed
description OBJECTIVES: Oral squamous cell carcinoma (OSCC) is a commonly reported cancer in men and is second only to breast cancer in women in Pakistan.. Investigations for identifying biomarkers of OSCC are essential for diagnostic, therapeutic, or prognostic significance. This study aims to examine the miR-31 expression in the pre- and post-operative OSCC patients and correlate this expression with clinicopathological characteristics. METHODS: Patients with histopathologically confirmed OSCC who had undergone surgical resections of tumours were recruited. A total of 40 saliva samples (pre- and post-operative) were collected from 19 patients and two healthy individuals. Levels of salivary miR-31 expressions were examined through quantitative reverse transcription polymerase chain reaction. RESULTS: The salivary miR-31 expression was significantly higher in the preoperative patients than in postoperative patients (p < 0.001). However, no significant correlation had been found between the salivary miR-31 expression and clinicopathological characteristics (p > 0.05). CONCLUSION: Our data suggest that miR-31 can be used as an adjunct non-invasive marker to monitor surgery outcomes during postoperative follow-up in patients with OSCC.
format Online
Article
Text
id pubmed-8498719
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taibah University
record_format MEDLINE/PubMed
spelling pubmed-84987192021-10-21 Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma Kumari, Parma Syed, Sofia A. Wahid, Mohsin Qureshi, Muhammad A. Kumar, Rajesh J Taibah Univ Med Sci Original Article OBJECTIVES: Oral squamous cell carcinoma (OSCC) is a commonly reported cancer in men and is second only to breast cancer in women in Pakistan.. Investigations for identifying biomarkers of OSCC are essential for diagnostic, therapeutic, or prognostic significance. This study aims to examine the miR-31 expression in the pre- and post-operative OSCC patients and correlate this expression with clinicopathological characteristics. METHODS: Patients with histopathologically confirmed OSCC who had undergone surgical resections of tumours were recruited. A total of 40 saliva samples (pre- and post-operative) were collected from 19 patients and two healthy individuals. Levels of salivary miR-31 expressions were examined through quantitative reverse transcription polymerase chain reaction. RESULTS: The salivary miR-31 expression was significantly higher in the preoperative patients than in postoperative patients (p < 0.001). However, no significant correlation had been found between the salivary miR-31 expression and clinicopathological characteristics (p > 0.05). CONCLUSION: Our data suggest that miR-31 can be used as an adjunct non-invasive marker to monitor surgery outcomes during postoperative follow-up in patients with OSCC. Taibah University 2021-04-22 /pmc/articles/PMC8498719/ /pubmed/34690655 http://dx.doi.org/10.1016/j.jtumed.2021.03.007 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Kumari, Parma
Syed, Sofia A.
Wahid, Mohsin
Qureshi, Muhammad A.
Kumar, Rajesh
Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma
title Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma
title_full Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma
title_fullStr Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma
title_full_unstemmed Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma
title_short Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma
title_sort expression of mir-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498719/
https://www.ncbi.nlm.nih.gov/pubmed/34690655
http://dx.doi.org/10.1016/j.jtumed.2021.03.007
work_keys_str_mv AT kumariparma expressionofmir31insalivaliquidbiopsyinpatientswithoralsquamouscellcarcinoma
AT syedsofiaa expressionofmir31insalivaliquidbiopsyinpatientswithoralsquamouscellcarcinoma
AT wahidmohsin expressionofmir31insalivaliquidbiopsyinpatientswithoralsquamouscellcarcinoma
AT qureshimuhammada expressionofmir31insalivaliquidbiopsyinpatientswithoralsquamouscellcarcinoma
AT kumarrajesh expressionofmir31insalivaliquidbiopsyinpatientswithoralsquamouscellcarcinoma